KaufmanKOlsenEAWhitingD. Finasteride in the treatment of men with androgenetic alopecia. J Am Acad Dermatol1998; 39:578–589.
5.
LeydenJDunlapFMillerB. Finasteride in the treatment of men with frontal male pattern hair loss. J Am Acad Dermatol1999; 40:930–937.
6.
RobertsJHordinskyMOlsenE. The effects of finasteride on postmenopausal women with androgenetic alopecia [abstract]. Hair Workshop, Brussels: Belgium, 1998:16.
7.
EkoeJBurckhardtPRuediB. Treatment of hirsutism, acne and alopecia with cyproterone acetate. Dermatologica1980; 160:398–404.
8.
BurkeBCunliffeW. Oral spironolactone therapy for female patients with acne, hirsutism or androgenic alopecia. Br J Dermatol1985; 112:124–125.
9.
RushtonDH. Quantitative assessment of spironolactone treatment in women with diffuse androgen-dependent alopecia. J Soc Cosmet Chemists1991; 42:317–325.
10.
PriceVMenefeeE. Quantitative estimation of hair growth: Comparative changes in weight and hair count with 5% and 2% minoxidil, placebo and no treatment. In: Van NesteDRandallV, eds. Hair research for the next millenium. Amsterdam: Elsevier Science, 1996:67–68.
11.
DeVillezRJacobsJSzpunarC. Androgenetic alopecia in the female: Treatment with 2% minoxidil solution. Arch Dermatol1994; 130:303–307.
12.
DianiARMulhollandMJShullKL. Hair growth effects of oral administration of finasteride, a steroid 5 alpha reductase inhibitor, alone and in combination with topical minoxidil in the balding stumptail macque. J Clin Endocrinol1992; 4:345–350.